Innovation is at the heart of our company, our pedigree started with a collaboration between the company owner and Dr Archie Brain, leading to the introduction of a product that changed the way clinicians managed airways throughout the world, becoming a ubiquitous airway device and improving the care of countless patients.
Venner has maintained this collaboration with innovative clinicians constantly looking for ideas and solutions to address never events and clinical challenges in order to improve patient safety.
At Venner Medical International, we pride ourselves on transforming clinician-led, research-driven ideas into innovative medical technologies designed to solve real problems and improve health outcomes for patients.
Venner has a great team with many years of experience, along with both design and manufacturing facilities enabling the team to move quickly with rapid prototyping to test the market and potentially move to full production.
All our products are manufactured in ISO 13485:2016 certified, manufacturing plants in Singapore, China and the Seychelles that adhere to rigorous medical device/technology manufacturing standards.
Our friendly customer services team and reliable supply chain and logistics network ensure your orders are fulfilled and delivered promptly and cost-efficiently.
Venner Medical complements each product purchase with extensive in-service training and on-going support delivered by our highly-skilled sales and marketing teams.
Currently our award-winning portfolio of products include pioneering airway management video technology, a ventilator associated pneumonia prevention system, An innovative packaging solution that can prevent guidewire retention and a monitoring system which reduces the incidence of pharmaceutical theft.
Venner Medical is currently looking for procedure pack companies and other interested parties to help stop Guidewire retention by implementing the only human factors based solution on the market WireSafeTMView product
The Venner PneuX™ System is associated with a significant reduction in VAP. This can potentially lead to significant cost reductions and should be implemented as part of the VAP reduction bundle.